Chief Executive Officer
Neuclone PTY LTD, Australia
Dr Sunstrom has been the CEO of NeuClone since it was established in 2007. Dr Sunstrum has over 15 years experience in the biopharmaceutical industry including more than 10 years of executive experience in biopharmaceutical companies. Dr Sunstrom has led teams in product development from laboratory to the market and founded and led two biotechnology companies in the area of CHO cell line development. Dr Sunstrom has held previous positions as CSO and Co-Founder of Acyte Biotech Pty Ltd as well as Deputy Director of both the CRC for Biopharmaceutical Research and the Bioengineering Centre at the University of New South Wales.
GMP production, therapeutic monoclonal antibody, clinical trials, biosimilars, autoimmune diseases